


| Key | % Net Assets |
|---|---|
| 2.5% | |
| 2.4% | |
| 2.1% | |
| 2.0% | |
| 91% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 2.5% |
| AstraZeneca | 2.4% |
| Reynolds American | 2.1% |
| Vodafone | 2.0% |
| British American Tobacco | 2.0% |
| BG | 2.0% |
| Imperial Tobacco | 1.6% |
| BP | 1.5% |
| National Grid | 1.5% |
| Tesco | 1.5% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 112.43p |
| Currency | GBP |
| Change | 0.15p |
| % | 0.13% |
| YTD change | 4.06p |
| YTD % | 3.75% |
| Fund Inception | 26/01/2004 |
|---|---|
| Fund Manager | Paul Causer / Paul Read / Neil Woodford |
| TER | 1.07 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.04% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research